CeriBell Financials
| CBLL Stock | 21.05 0.88 4.01% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 15.81 | 15.05 |
|
|
Investors should never underestimate CeriBell's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor CeriBell's cash flow, debt, and profitability to make informed and accurate decisions about investing in CeriBell.
Net Income |
|
CeriBell | Select Account or Indicator | Build AI portfolio with CeriBell Stock |
Understanding current and past CeriBell Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of CeriBell's financial statements are interrelated, with each one affecting the others. For example, an increase in CeriBell's assets may result in an increase in income on the income statement.
CeriBell Stock Summary
CeriBell competes with Treace Medical, Orthopediatrics Corp, Standard Biotools, Enhabit, and QuantumSi. CeriBell is entity of United States. It is traded as Stock on NASDAQ exchange.Specialization | Health Care, Health Care Equipment & Services |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US15678C1027 |
| Business Address | 360 North Pastoria |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.ceribell.com |
| Phone | 800 436 0826 |
CeriBell Key Financial Ratios
| Return On Equity | -0.6 | ||||
| Profit Margin | (0.63) % | ||||
| Operating Margin | (0.65) % | ||||
| Price To Sales | 9.82 X | ||||
| Revenue | 65.44 M |
CeriBell Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining CeriBell's current stock value. Our valuation model uses many indicators to compare CeriBell value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CeriBell competition to find correlations between indicators driving CeriBell's intrinsic value. More Info.CeriBell is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, CeriBell's Return On Equity is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value CeriBell by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.CeriBell Systematic Risk
CeriBell's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. CeriBell volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty with a total number of output elements of thirty-one. The Beta measures systematic risk based on how returns on CeriBell correlated with the market. If Beta is less than 0 CeriBell generally moves in the opposite direction as compared to the market. If CeriBell Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one CeriBell is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of CeriBell is generally in the same direction as the market. If Beta > 1 CeriBell moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in CeriBell Stock are looking for potential investment opportunities by analyzing not only static indicators but also various CeriBell's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of CeriBell growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
CeriBell January 2, 2026 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of CeriBell help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of CeriBell. We use our internally-developed statistical techniques to arrive at the intrinsic value of CeriBell based on widely used predictive technical indicators. In general, we focus on analyzing CeriBell Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build CeriBell's daily price indicators and compare them against related drivers.
| Downside Deviation | 3.13 | |||
| Information Ratio | 0.2683 | |||
| Maximum Drawdown | 16.78 | |||
| Value At Risk | (5.90) | |||
| Potential Upside | 7.04 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CeriBell. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy CeriBell Stock please use our How to buy in CeriBell Stock guide.You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CeriBell. If investors know CeriBell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CeriBell listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.67) | Revenue Per Share | Quarterly Revenue Growth 0.314 | Return On Assets | Return On Equity |
The market value of CeriBell is measured differently than its book value, which is the value of CeriBell that is recorded on the company's balance sheet. Investors also form their own opinion of CeriBell's value that differs from its market value or its book value, called intrinsic value, which is CeriBell's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CeriBell's market value can be influenced by many factors that don't directly affect CeriBell's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CeriBell's value and its price as these two are different measures arrived at by different means. Investors typically determine if CeriBell is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CeriBell's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.